Dr. Zhenyi Su is an Associate Research Scientist at Herbert Irving Cancer Research Center, Columbia University, New York, USA. He has received his PhD from Beijing Normal University, College of Life Science, China, in the year 2012. Later, He has completed his MS from Beijing Normal University, China. He Worked as a Lecturer at Southeast University Medical School, China from 2012-2018. Dr. Zhenyi Su has published several papers in reputed journals and her research interests include Regulated cell death (ferroptosis, necroptosis, apoptosis, etc.) and cancer progression; Reprogramming Innate immunity for cancer therapy.
Regulated cell death, cancer progression; Reprogramming Innate immunity for cancer therapy, Gain-of-function of mutant p53 in cancer metastasis.
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.